Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fang

Showing results (371-380 of 535) with videos related to

Pageof 54
Sort By:
ESMO Open|November 28, 2022
Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitorL-N He, S Fu, H Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes]H J Huang, Z X Shi, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 27, 2025
[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia]Z X Kuang, J Y Zhao, X Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing]B Li, J Y Wang, J Q Liu, et al.
Nature Communications|April 12, 2013
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherinM I Setyawati, C Y Tay, S L Chia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 31, 2025
[Analysis of treatment response and post-discontinuation efficacy maintenance of cyclophosphamide monotherapy in T-cell large granular lymphocytic leukemia]L L Zhang, L Z Tian, H Pan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 2, 2019
[A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees]Z F Xu, T J Qin, H L Zhang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 30, 2020
[The Breast Cancer Cohort Study in Chinese Women: the methodology of population-based cohort and baseline characteristics]H L Bao, L Y Liu, L W Fang, et al.
The New England Journal of Medicine|May 23, 2019
Nasal High-Flow Therapy for Newborn Infants in Special Care NurseriesBrett J Manley, Gaston R B Arnolda, Ian M R Wright, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 19, 2016
[Prognostic value of JAK2, MPL and CALR mutations in Chinese patients with primary myelofibrosis]Z F Xu, B Li, J Q Liu, et al.
Pageof 54

Showing results (371-380 of 535) with videos related to

Sort By:
Pageof 54
ESMO Open|November 28, 2022
Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitorL-N He, S Fu, H Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes]H J Huang, Z X Shi, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 27, 2025
[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia]Z X Kuang, J Y Zhao, X Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing]B Li, J Y Wang, J Q Liu, et al.
Nature Communications|April 12, 2013
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherinM I Setyawati, C Y Tay, S L Chia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 31, 2025
[Analysis of treatment response and post-discontinuation efficacy maintenance of cyclophosphamide monotherapy in T-cell large granular lymphocytic leukemia]L L Zhang, L Z Tian, H Pan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 2, 2019
[A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees]Z F Xu, T J Qin, H L Zhang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 30, 2020
[The Breast Cancer Cohort Study in Chinese Women: the methodology of population-based cohort and baseline characteristics]H L Bao, L Y Liu, L W Fang, et al.
The New England Journal of Medicine|May 23, 2019
Nasal High-Flow Therapy for Newborn Infants in Special Care NurseriesBrett J Manley, Gaston R B Arnolda, Ian M R Wright, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 19, 2016
[Prognostic value of JAK2, MPL and CALR mutations in Chinese patients with primary myelofibrosis]Z F Xu, B Li, J Q Liu, et al.
Pageof 54